| Schedule of Common Stock Warrant Activity |
The following table presents the Company’s common stock warrant activity during the six months ended June 30, 2026: | | | Number of Shares
Underlying Warrants | | | Weighted Average
Exercise Price | | | Weighted Average
Remaining Term (Years) | | | Outstanding as of December 31, 2025 | | | 2,033,467 | | | $ | 2.27 | | | | 2.72 | | | Granted | | | - | | | | - | | | | - | | | Exercises | | | - | | | | - | | | | - | | | Outstanding and exercisable as of June 30, 2026 | | | 2,033,467 | | | $ | 2.27 | | | | 2.22 | |
|
The following table presents the Company’s common stock warrant activity for the years ended December 31, 2025 and 2024: | | | Number of
Shares
Underlying
Warrants | | | Weighted
Average Exercise
Price | | | Weighted Average
Remaining Term
(Years) | | | Outstanding and exercisable as of January 1, 2024 | | | 2,035,135 | | | $ | 1.96 | | | | 4.28 | | | Granted | | | 200,000 | | | | 2.28 | | | | - | | | Exercises | | | (175,001 | ) | | | 2.00 | | | | - | | | Outstanding and exercisable as of December 31, 2024 | | | 2,060,134 | | | $ | 2.28 | | | | 3.71 | | | Exercises | | | (26,667 | ) | | $ | 1.81 | | | | - | | | Outstanding and exercisable as of December 31, 2025 | | | 2,033,467 | | | $ | 2.27 | | | | 2.72 | |
|